切换至 "中华医学电子期刊资源库"
高级检索
中华腔镜泌尿外科杂志(电子版)

中华腔镜泌尿外科杂志(电子版) ›› 2020, Vol. 14 ›› Issue (01) : 56 -60. doi: 10.3877/cma.j.issn.1674-3253.2020.01.014

所属专题： 文献；

临床研究

体外热电场治疗在男性慢性盆腔疼痛综合征中的应用
丁虹璐1, 冯经纬1, 吴珍1, 陈嘉良1, 刘柏隆1, 林志钧1, 谢俊聪1, 许源城1, 周祥福1,†()   
  1. 1. 510630　广州，中山大学附属第三医院泌尿外科
  • 收稿日期:2019-06-09 出版日期:2020-02-01
  • 通信作者: 周祥福
  • 基金资助:
    国家自然科学基金(81670688、81800666); 广东省自然科学基金(2016A030313192、2017A030310414、2018A0303130330); 广东省医学科学技术研究基金项目(A2017365); 高校基本科研业务费-青年教师培育项目(19ykpy33)

Application of thermoelectric field therapy in chronic prostatitis/chronic pelvic pain syndrome

Honglu Ding1, Jingwei Feng1, Zhen Wu1, Jialiang Chen1, Bolong Liu1, Zhijun Lin1, Juncong Xie1, Yuancheng Xu1, Xiangfu Zhou1,†()   

  1. 1. Department of Urology, the Third Affliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2019-06-09 Published:2020-02-01
  • Corresponding author: Xiangfu Zhou
  • About author:
    Corresponding author: Zhou Xiangfu, Email:
全文 ( ) 下载PDF ( ) 导出引用
引用本文：

丁虹璐, 冯经纬, 吴珍, 陈嘉良, 刘柏隆, 林志钧, 谢俊聪, 许源城, 周祥福. 体外热电场治疗在男性慢性盆腔疼痛综合征中的应用[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2020, 14(01): 56-60.

Honglu Ding, Jingwei Feng, Zhen Wu, Jialiang Chen, Bolong Liu, Zhijun Lin, Juncong Xie, Yuancheng Xu, Xiangfu Zhou. Application of thermoelectric field therapy in chronic prostatitis/chronic pelvic pain syndrome[J/OL]. Chinese Journal of Endourology(Electronic Edition), 2020, 14(01): 56-60.

目的

从多方面评估体外热电场治疗对男性慢性前列腺炎/慢性盆腔疼痛综合征（CP/CPPS）患者症状的改善情况并进行疗效分析，进而判断其临床应用价值。

方法

回顾性收集2018年4月至2019年3月，57例使用LR-2005体外热电场治疗机进行治疗的CP/CPPS患者的临床资料，并对其治疗前后所填评分量表进行统计学分析。患者20～50岁，病程3个月～7年，其中行1个疗程治疗17例，2个疗程32例，3个疗程8例。所用评分量表包括：NIH-CPSI评分、PUF评分、VAS评分、QOL评分、SAS评分、SDS评分等。

结果

治疗前与治疗后，患者NIH-CPSI总评分分别为（25.05±6.32） vs （19.54±6.16）、PUF症状评分为（10.86±4.41） vs （8.46±4.11）、PUF困扰评分为（5.35±2.88） vs （4.03±2.33)、VAS评分为（3.97±2.40） vs （2.03±1.85）、QOL评分为（4.89±1.27）vs （3.95±1.25）、SAS评分为（37.35±8.76） vs （34.00±8.14）、SDS评分为（34.41±7.43） vs （32.05±4.78），治疗后均下降且与治疗前比较差异具有显著统计学意义（P<0.01）。治疗后NIH-CPSI评分轻中度人数增加，重度人数明显减少，治疗前后差异具有显著统计学意义（P<0.01）。患者治疗后未见特殊不适或不良反应发生。

结论

体外热电场治疗能够有效减轻CP/CPPS患者炎症和疼痛反应，改善排尿症状，降低焦虑抑郁程度，提高患者生活质量。其临床疗效显著，治疗有效率高，符合WHO倡导的"无痛、无创、非介入"的治疗模式，患者容易接受，值得临床推广。

关键词: 体外热电场治疗, CP/CPPS, 慢性，盆腔疼痛综合征, 慢性，前列腺炎
Objective

To evaluate the improvement of symptoms in patients with chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS) treated by thermoelectric field therapy.

Methods

From April 2018 to March 2019, 57 CP/CPPS patients treated by LR-2005 thermoelectric field therapeutic Machine. The patients were aged 20-50 years, and the course of the disease was ranged from 3 months to 7 years. Among them, 17 patients with one period of therapy, 32 patients with two period of therapy, and the rest with three. Each patient underwent clinical assessment and answered the questionnaire consisted of NIH-CPSI,PUF, VAS, QOL, SAS and SDS. Compared and analyzed the scores statistically.

Results

After treatment, the NIH-CPSI total score [(25.05±6.32) vs (19.54±6.16)], PUF symptom score [(10.86±4.41) vs (8.46±4.11)], PUF distress score [(5.35 ± 2.88) vs (4.03±2.33)], VAS score [(3.97±2.40) vs (2.03±1.85)], QOL score [(4.89±1.27) vs (3.95±1.25)], SAS score [(37.35±8.76) vs (34.00±8.14)], SDS score [(34.41±7.43) vs (32.05±4.78)] were all decreased significantly (P<0.01). The NIH-CPSI score increased in numbers of mild and moderate, while the severe decreased significantly (P<0.01). No special discomfort or adverse reactions occurred after treatment.

Conclusion

Thermoelectric field therapy can effectively alleviate inflammation and pain response, improve voiding symptoms, reduce anxiety and depression of CP/CPPS patients, and improve the quality of life. Its clinical curative effect is remarkable, and it fits the "painless, non-invasive and non-interventional" treatment model advocated by WHO. It was worth of promoting in clinical application.

Key words: Thermoelectric field therapy, CP/CPSS, Chronic, pelvic pain syndrome, Chronic, prostatitis
表1 57例CP/CPPS患者治疗前后各评分量表得分对比(分，±s)
? NIH-CPSI PUF症状 PUF困扰 VAS QOL SDS SAS
治疗前 25.05±6.32 10.86±4.41 5.35±2.88 3.97±2.40 4.89±1.27 37.35±8.76 34.41±7.43
治疗后 19.54±6.16 8.46±4.11 4.03±2.33 2.03±1.85 3.95±1.25 34.00±8.14 32.05±4.78
t值 9.076 10.118 6.674 8.784 8.471 6.491 6.833
P值 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001
表2 治疗前后NIH-CPSI评分表轻中重度人群分布[例（%）]
? NIH-CPSI疼痛症状评分 NIH-CPSI总评分
轻 中 重 轻 中 重
治疗前 11（19.3%） 37（64.9%） 9（15.8%） 3（5.3%） 37（64.9%） 17（29.8%）
治疗后 29（50.9%） 26（45.6%） 2（3.5%） 13（22.8%） 42（73.7%） 2（3.5%）
χ2值 14.48 9.73
P值 <0.001 <0.001
[1]
Holt JD, Garrett WA, Mccurry TK, et al. Common questions about chronic prostatitis[J]. Am Fam Physician, 2016, 93(4): 290-296.
[2]
唐园，姜庆, 等. 慢性前列腺炎/慢性骨盆疼痛综合征治疗进展[J].科学咨询(科技·管理), 2016, 6(2): 71-73.
[3]
Suskind AM, Berry SH, Ewing BA.et al. The prevalence and ovedap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiologymale study[J]．J Urol, 2013, 189(1): 141-145.
[4]
郭应禄，胡礼泉. 男科学[M]. 北京:人民卫生出版社, 2005: 1488-1493.
[5]
齐旻芳，黄高翔，周雪娟.慢性非细菌性前列腺炎发病机制的研究进展[J]. 广西医科大学学报, 2017, 34(8): 1247-1249.
[6]
蓝天，王养民，陈烨, 等. 慢性前列腺炎相关危险因素的多中心联合调查研究[J]. 解放军医学杂志, 2010, 35(1): 79-82.
[7]
Giubilei G, Mondaini N, Minervini A, et al. Physical activity of men with chronic prostatitis/chronic pelvic pain syndrome not satisfied with conventional treatments. Could it represent avalid option the physical activity and male pelvic pain trial: Adouble-blind, randomized study[J]. J Urol, 2007, 177(1): 159-165.
[8]
邝世航，黄双艺，乐有为, 等. 慢性前列腺炎TGF-β1、CTGF的表达水平及其与症状指数的关系[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(2): 125-128.
[9]
邓云山. 慢性前列腺炎患者抑郁状况分析[J]. 中国性科学, 2012, 21(9): 5-8.
[10]
Mo MQ, Long LL, Xie WL, et al. Sexual dysfunctions and psychological disorders associated with type Ⅲa chronic prostatitis:a clinical survey in China[J]. Int Urol Nephrol, 2014, 46 (12): 2255-226．
[11]
李春弟，崔巍，蒋聿瑛. 慢性前列腺炎/慢性骨盆疼痛综合征的发病相关危险因素分析[J].中国现代医生, 2015, 53(13): 77-80.
[12]
Tripp DA, Nickel JC, Shoskes D, et al. A 2-year follow-up of quality of life, pain, and psychosocial factors in patients with chronic prostatitis /chronic pelvic pain syndrome and their spouses[J]. World J Urol, 2013, 31(4): 733-739．
[13]
Guan X, Zhao C, OU ZY, et al. Use of the UPOI NT phenotype system in treating Chinese patients with chronic prostatitis/chronic pelvic pain syndrome: a prospective study[J].Asian J Androl, 2015, 17(1): 120.
[14]
Shoskes DA, Nickel JC. Classification and treatment of men with chronic prostatitis/chronic pelvic pain syndrome using the uPOINT system[J].world J Urol, 2013, 31(4): 55-760.
[15]
张志超，彭靖.慢性前列腺炎/慢性盆腔疼痛综合征的新诊断/治疗模式-UPOINT系统[J]. 中华男科学杂志, 2013, 19(7): 579-582.
[16]
陈萍，张纪良，朱丽, 等. 化疗与热疗联合治疗晚期非小细胞肺癌的临床研究[J]. 现代临床医学, 2019, 45(4): 1-3.
[17]
WAN J, WU W. Hyperthermia induced HIF-1α expression of lung cancer through AKT and ERK signaling pathways[J]. J Exp Clin Cancer Res, 2016, 35(1): 119-129.
[18]
LEE H, KIM S, CHOI B H, et al. Hyperthermia improves therapeutic efficacy of doxorubicin carried by mesoporous silica nanocontainers in human lung cancer cells[J]. Int J Hyperthermia, 2011, 27(7): 698-707.
[19]
沈海兰. 慢性盆腔炎抗炎加盆腔深部热疗临床观察[J]. 中西医结合心血管病电子杂志, 2017, 5(30): 58-59.
[20]
刘行峰，张军杰, 等. 高频热疗机治疗慢性盆地疼痛综合征观察[J].河南外科杂志, 2004, 10(4): 76-77.
[21]
邓国政，吴媛，杨晓琼. 体外热电场辅以灌肠治疗溃疡性结肠炎28例[J]. 光明中医, 2014, 29(1): 132-133.
No related articles found!
阅读次数
全文


摘要

版权所有 中华医学会 中华医学电子音像出版社有限责任公司  京ICP备14006079号-1  网络出版服务许可证：(署)网出证(京)字第075号